| Primary Device ID | 15051716000305 |
| NIH Device Record Key | 19e99fa4-a37a-4a9b-afa6-72d912e3d30b |
| Commercial Distribution Status | In Commercial Distribution |
| Brand Name | T-SPOT®.TB8 |
| Version Model Number | TB.300 |
| Catalog Number | TB.300US |
| Company DUNS | 009744265 |
| Company Name | Oxford Immunotec, Inc. |
| Device Count | 1 |
| DM Exempt | true |
| Pre-market Exempt | false |
| MRI Safety Status | Labeling does not contain MRI Safety Information |
| Human Cell/Tissue Product | false |
| Device Kit | true |
| Device Combination Product | false |
| Single Use | false |
| Lot Batch | true |
| Serial Number | false |
| Manufacturing Date | false |
| Expiration Date | true |
| Donation Id Number | false |
| Contains Natural Rubber Latex | false |
| Labeled No Natural Rubber Latex | false |
| RX Perscription | false |
| OTC Over-The-Counter | false |
| Handling Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius |
| Handling Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius |
| Device Issuing Agency | Device ID |
|---|---|
| GS1 | 15051716000305 [Primary] |
| OJN | Mycobacterium Tuberculosis, Cell Mediated Immune Response, Enzyme-Linked Immunospot Test |
| Steralize Prior To Use | false |
| Device Is Sterile | false |
| Public Version Status | Update |
| Device Record Status | Published |
| Public Version Number | 3 |
| Public Version Date | 2018-07-06 |
| Device Publish Date | 2014-08-12 |
| 05051716000544 - Leucosep Tubes | 2023-04-10 Leucosep® tubes are intended for use in the collection and separation of peripheral blood mononuclear cells (PBMCs) from whole |
| 05051716000087 - Leucosep Tubes | 2023-02-15 Leucosep® tubes are intended for use in the collection and separation of peripheral blood mononuclear cells (PBMCs) from whole |
| 05051716000155 - AIM-V Medium | 2023-02-15 AIM-V® serum free cell culture medium is intended for use in the preparation of peripheral blood mononuclear cells (PBMCs) from |
| 05051716000162 - AIM-V Medium | 2023-02-15 AIM-V® serum free cell culture medium is intended for use in the preparation of peripheral blood mononuclear cells (PBMCs) from |
| 05051716000186 - T-Cell Select® | 2023-02-15 The T-SPOT.TB test has been evaluated for the processing of blood samples within 8 hours of venipuncture. With the T-Cell Select |
| 15051716000008 - T-SPOT®.TB96 | 2018-07-06 For the detection of effector t cells that respond to stimulation by mycobacterium tuberculosis antigens esat-6 and cfp-10 and i |
| 15051716000022 - T.Cell Xtend® | 2018-07-06 Approval for the use of t-cell xtend reagent with the t-spot. Tb test, in order to extend the time from sample collection to sam |
| 15051716000046 - T-SPOT®.TB50 | 2018-07-06 For the detection of effector t cells that respond to stimulation by mycobacterium tuberculosis antigens esat-6 and cfp-10 and i |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() T-SPOT 78437297 3665044 Live/Registered |
Oxford Immunotec Limited 2004-06-17 |
![]() T-SPOT 77608590 not registered Dead/Abandoned |
Edward Abel 2008-11-06 |
![]() T-SPOT 77608576 not registered Dead/Abandoned |
Edward Abel 2008-11-06 |
![]() T-SPOT 75899961 not registered Dead/Abandoned |
CASE WESTERN RESERVE UNIVERSITY 2000-01-19 |
![]() T-SPOT 75199458 not registered Dead/Abandoned |
ATHERSYS, INC. 1996-11-18 |